Skip to content

Ketamine: all studies

Page 114 of 448: studies 1,131 to 1,140 of 4,475, newest first. Back to the ketamine overview

Research

Ketamine-induced cystitis: A case report and literature review.

Radiology case reports December 1, 2024 Juan Felipe Betancur, Melina González Diaz Granados, Nancy Toro et al. 3 citations

Ketamine, a dissociative anesthetic drug, has gained popularity as a recreational substance, particularly among young adults. However, chronic ketamine abuse can lead to various complications including ketamine-induced cystitis. We present the case of a 46-year-old Caucasian male with a history of HIV infection and daily recreational ketamine use for 7 months, who was admitted to the emergency...

DOI: 10.1016/j.radcr.2024.08.053 (opens in new tab) Full text (opens in new tab) Bladder thickening Hematuria Recreational drug use Ureteropyeloscopy +5

Low-dose ketamine for acute pain: A narrative review.

The American Journal of Emergency Medicine December 1, 2024 Robert G Fuller, Evan M Kikla, Andrew P W Fawcett et al. 12 citations

Acute pain management is a critical component of prehospital and emergency medical care. Opioids are effective; however, the risks and side-effects of opioids have led providers to use low-dose ketamine (LDK) for safe and effective treatment of acute pain. We conducted a scoping narrative review to explore the efficacy of LDK for the treatment of acute pain in the prehospital setting and...

(2R,6R)-hydroxynorketamine alleviates PTSD-like endophenotypes by regulating the PI3K/AKT signaling pathway in rats.

Pharmacology, Biochemistry, and Behavior December 1, 2024 Lifen Liu, Rui Li, Lanxia Wu et al. 3 citations

Patients diagnosed with post-traumatic stress disorder (PTSD) mainly exhibit enduring adverse emotions, heightening susceptibility to suicidal thoughts and behaviors. Notably, metabolites of ketamine, particularly (2R,6R)-hydroxyketamine (HNK), have demonstrated favorable antidepressant properties. However, the precise mechanism through which HNK exerts its therapeutic effects on negative...

Ketamine modulates the exploratory dynamics and homebase-related behaviors of adult zebrafish.

Pharmacology, Biochemistry, and Behavior December 1, 2024 Camilla W Pretzel, João V Borba, Cássio M Resmim et al. 5 citations

Anxiety can be a protective emotion when animals face aversive conditions, but is commonly associated with various neuropsychiatric disorders when pathologically exacerbated. Drug repurposing has emerged as a valuable strategy based on utilizing the existing pharmaceuticals for new therapeutic purposes. Ketamine, traditionally used as an anesthetic, acts as a non-competitive antagonist of the...

DOI: 10.1016/j.pbb.2024.173892 (opens in new tab) Full text (opens in new tab) Nmda receptor Open field test Spatio-temporal exploration Stereotyped behavior +6

Molecular signature underlying (R)-ketamine rapid antidepressant response on anhedonic-like behavior induced by sustained exposure to stress.

Pharmacology, Biochemistry, and Behavior December 1, 2024 Ellen Scotton, Paola Rampelotto Ziani, Renata Luiza Boff Wilges et al. 1 citation

Anhedonia induced by sustained stress exposure is a hallmark symptom of major depressive disorder (MDD) and in rodents, it can be accessed through the sucrose preference test (SPT). (R)-ketamine is a fast-acting antidepressant with less detrimental side effects and abuse liability compared to racemic ketamine. The present study combined high-throughput proteomics and network analysis to...

DOI: 10.1016/j.pbb.2024.173882 (opens in new tab) Full text (opens in new tab) Major depressive disorder R-ketamine treatment response Anhedonic-like behavior Molecular targets +6

Intravenous ketamine infusions in patients with depression and Epilepsy: Case series.

Journal of Clinical Neuroscience December 1, 2024 Mariusz Stanisław Wiglusz, Zuzanna Chmielewska, Wiesław Jerzy Cubała 1 citation

Mood disorders affect approximately one-third of individuals with epilepsy, posing an increased risk of suicide. There is an unquestionable need for more effective antidepressant treatment in this group of patients. This study explores the safety and tolerability of low-dose intravenous ketamine in six patients with comorbid depression and epilepsy. This report is limited to the post-hoc...

DOI: 10.1016/j.jocn.2024.110908 (opens in new tab) Full text (opens in new tab) Case report Intravenous #depression-treatment depression therapy Mood disorder treatment +6

Splenic γδ T cells mediate antidepressant and prophylactic actions of arketamine in lipopolysaccharide-induced depression in mice.

Pharmacology, Biochemistry, and Behavior December 1, 2024 Guilin Liu, Li Ma, Akemi Sakamoto et al. 4 citations

Arketamine, the (R)-enantiomer of ketamine, exhibits both therapeutic and sustained prophylactic effects in an inflammation-driven model of depression, although the precise mechanisms remain elusive. Given the involvement of γδ T cells in inflammatory processes, this study explored their role in the effects of arketamine. To assess therapeutic outcomes, mice received lipopolysaccharide (LPS:1.0...

DOI: 10.1016/j.pbb.2024.173906 (opens in new tab) Full text (opens in new tab) Arketamine Prophylactic Spleen Antidepressants antidepressant medication +8

Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis of Esketamine and Respiratory Depression.

The International Journal of Neuropsychopharmacology December 1, 2024 Craig Chepke, Richard C. Shelton, Gerard Sanacora et al. 7 citations

Esketamine nasal spray (ESK) is approved, in conjunction with an oral antidepressant, for the treatment of treatment-resistant depression in adults and for the treatment of depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. No adverse events (AEs) of respiratory depression were reported in ESK phase 3 clinical trials; however, postmarketing...

DOI: 10.1093/ijnp/pyae058 (opens in new tab) Full text (opens in new tab) Esketamine nasal spray Respiratory depression Depression treatment Esketamine therapy +3

Safety and efficacy of ketamine use in patients with vaso-occlusive crisis: A systematic review and meta-analysis.

EJHaem December 1, 2024 Ernesto Calderon Martinez, Stephin Zachariah Saji, Thomas Campos Carmona et al. 2 citations

Sickle cell disease (SCD) is characterized by acute episodes called vaso-occlusive crises (VOC). VOC is marked by severe pain due to blocked blood vessels by sickled cells. Ketamine has been reported to be effective and safe in managing VOC in SCD patients. This review aims to determine ketamine's safety and efficacy through analysis of clinical trials and observational studies. Adhering to...

DOI: 10.1002/jha2.1050 (opens in new tab) Full text (opens in new tab) Opioids Pain management Vaso‐occlusive crisis voc Ketamine therapy +3

General Anesthesia Occludes Ketamine's Antidepressant Response in a Rodent Model of Chronic Stress.

Psychedelic Medicine December 1, 2024 Daniel Markman, Andrzej Z Wasilczuk, Joseph Michael Cichon 2 citations

Psychedelic-induced experiences are thought to play an important role in the therapeutic actions of rapid-acting antidepressants. General anesthesia is one scenario in which patients can be rendered unconscious and masked to the psychedelic treatment, providing a simple yet effective method to examine drug-induced changes in the brain devoid of experiences. Chronically stressed adult C57/BL6...

DOI: 10.1089/psymed.2024.0007 (opens in new tab) Full text (opens in new tab) Antidepressant response Chronic stress Dissociation General anesthesia +6